Disc Medicine (IRON) Return on Invested Capital (2023 - 2026)

Disc Medicine (IRON) has 3 years of Return on Invested Capital data on file, last reported at 0.02% in Q1 2026.

• On a quarterly basis, Return on Invested Capital rose 1.0% year-over-year to 0.02% in Q1 2026; TTM through Mar 2026 was 0.02%, a 1.0% increase from a year earlier, with the FY2025 full-year figure at 0.06%, changed N/A from the prior year.
• Return on Invested Capital for Q1 2026 stood at 0.02%, down from 0.02% in the prior quarter.
• Over the last five years, Return on Invested Capital for IRON reached as high as 0.02% in Q4 2025 and fell as low as 0.13% in Q1 2023.
• Historically, Return on Invested Capital has averaged 0.04% across 3 years, with a median of 0.02% in 2025.
• On a YoY basis, Return on Invested Capital climbed as much as 1 bps in 2026 and fell as far as 1 bps in 2026.
• Year by year, Return on Invested Capital stood at 0.13% in 2023, then jumped by 88 bps to 0.02% in 2025, then fell by 16 bps to 0.02% in 2026.
• Per Business Quant data, the three most recent Return on Invested Capital figures were 0.02% in Q1 2026, 0.02% in Q4 2025, and 0.02% in Q3 2025.